Dr. Boucher is an internationally recognized leader in antimicrobial drug development, with deep expertise in study design, and antimicrobial stewardship. She is a member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, and Treasurer of the Infectious Diseases Society of America. Dr. Boucher serves on the Board of Trustees of the Physicians of Tufts Medical Center and The College of the Holy Cross.
PhD | Director
Dr. Isberg’s expertise spans many infectious diseases and AMR. He is working to address AMR in pathogens including Acinetobacter baumanii. Dr. Isberg is a member of the National Academy of Sciences and was an investigator with the Howard Hughes Medical Institute for 27 years.
Dr. Leong is Edith Rieva and Hyman S. Trilling Professor and Chair of the Department of Molecular Biology and Microbiology at Tufts University School of Medicine. His research focuses on the interaction of pathogenic Escherichia coli, Borrelia burgdorferi (the Lyme disease spirochete) and Streptococcus pneumoniae with host immune and epithelial cells in order to understand the infectious process and develop novel therapies to prevent or treat these infections.
MD, FACP, FIDSA, FAST
Dr. Snydman has 35 years of experience in observational and interventional studies in translational research, including trials that resulted in FDA licensure of a biologic product. He has worked on epidemiologic aspects of antibiotic resistance for decades, focusing on hospital-acquired infections, anaerobes, C difficile, and MRSA. His current research is focused on the transmission of antibiotic resistance and C. difficile among nursing home patients and in health systems, as well as the impact of antimicrobial stewardship.